Imbio PHA (4.0.0) vs TOMTEC-ARENA
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA if your primary need is rapid, FDA-cleared, and automated analysis of CT pulmonary angiogram (CTPA) scans for assessing right ventricular dilation. This tool is specifically designed to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension by providing precise measurements of cardiac structures. Its focus on quick, specialized analysis makes it ideal for acute care settings where timely insights from CTPA are crucial.
View Imbio PHA (4.0.0) →Choose TOMTEC-ARENA if…
Choose TOMTEC-ARENA if your organization requires a highly flexible, vendor-neutral, and multimodality platform for advanced medical image analysis across cardiology and radiology. This solution is best suited for institutions needing comprehensive quantification, structured reporting, and web-based diagnostic workflows for 2D, 3D, and 4D image data from various imaging vendors. Its broad applicability and scalable architecture support diverse and complex diagnostic environments.
View TOMTEC-ARENA →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | TOMTEC-ARENA |
|---|---|---|
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | On-premise |
| FDA Status | Yes AI-estimated | Unknown |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TOMTEC-ARENAWhile both tools emphasize automation and integration, TOMTEC-ARENA's explicit focus on web-based diagnostic workflows via TOMTEC ZERO offers greater flexibility and accessibility, allowing diagnostic access from various locations and devices. User feedback also indicates a positive experience regarding speed, comfort, and user-friendliness.
Clinical Value
TieBoth tools demonstrate strong clinical value with FDA clearance and a focus on automated, reproducible measurements. Imbio PHA offers a highly specific, validated solution for pulmonary embolism and hypertension assessment, while TOMTEC-ARENA provides a broader, multimodality platform for advanced cardiac and radiology image analysis with a wide range of applications and robust quantification capabilities.
Pricing & Value
TOMTEC-ARENAWhile both require direct contact for pricing, TOMTEC-ARENA provides more transparency regarding its licensing structure, explicitly mentioning flexible, scalable, and tailored options, including models for small businesses and concurrent user licenses. This suggests a more adaptable and potentially value-driven approach for diverse customer needs.
Enterprise Readiness
Imbio PHA (4.0.0)Imbio PHA explicitly states third-party certified HIPAA compliance and implied BAA, which are crucial for enterprise adoption in healthcare. While TOMTEC-ARENA mentions meeting European data protection regulations and undergoing usability evaluations for FDA clearance, its HIPAA and BAA status are not explicitly stated as certified or available in the provided information, requiring direct vendor contact.
Innovation
TOMTEC-ARENATOMTEC-ARENA's innovation extends beyond specific measurements to a broader platform approach, offering multimodality, vendor-neutral analysis, and web-based workflows (TOMTEC ZERO) that enhance accessibility and flexibility across various imaging data types (2D, 3D, 4D). This comprehensive and adaptable architecture represents a more expansive innovation in the healthcare-AI space.
Support & Docs
TOMTEC-ARENATOMTEC-ARENA explicitly details a structured support offering, including premium service, maintenance contracts, extended warranties, and a network of factory-trained technicians. While Imbio provides contact information and user manuals, TOMTEC's comprehensive and explicitly outlined support framework suggests a more robust and proactive approach to customer service and documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | TOMTEC-ARENA |
|---|---|---|
| Name | Imbio PHA (4.0.0) | TOMTEC-ARENA |
| Company | Imbio | TOMTEC Imaging Systems GmbH |
| Specific AI Measurements | Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios. | AI-based measurement automation and data analytics; Advanced quantification for various medical specialties. |
| Multimodality/Vendor-Neutrality | Not specified | Multimodality and vendor-neutral imaging and analysis |
| Reporting Capabilities | Generates annotated DICOM images; Provides summary reports in PDF format. | Structured reporting capabilities; Automated archiving and data management. |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and TOMTEC-ARENA.